SM
RBOT

Sciencast Management’s Vicarious Surgical RBOT Stock Holding History

Sciencast Management’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,250
Closed -$177K – 624
2022
Q1 		$177K Buy
+1,250
New +$233K 0.04% 420

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sciencast Management's RBOT Position: Q2 2022 in Review

Sciencast Management sold out of Vicarious Surgical (RBOT) in Q2 2022, closing a stake of 1,250 shares — an estimated $177K sold.

Sciencast Management first reported a position in RBOT in Q1 2022 and held it in 1 quarter. The position peaked at $177K in Q1 2022. 79 funds tracked by Wall St. Rank hold RBOT as of Q2 2022.

  • Sciencast Management reported no remaining Vicarious Surgical position as of Q2 2022 after selling out during the quarter.
  • Sciencast Management sold 1,250 Vicarious Surgical shares in Q2 2022, an estimated $177K.
  • Sciencast Management first reported a position in Vicarious Surgical in Q1 2022 and held it in 1 quarter.
  • Sciencast Management's Vicarious Surgical position peaked at $177K in Q1 2022.
  • 79 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2022.

Based on Sciencast Management's 13F filing for Q2 2022, filed 3 Aug 2022.